The bottles affected by Wednesday's decision carry the labels: N229, N119,
N143, N180, N181, N190, N216, N218 and N219.
Clusters Sites Cluster specific amino acid changes KOL 507 (2007, 2009) 13 D26, N53, C59, L85, V95,
N143 (99%), T145, N171, T209, F214, T216, T217, T226 KOL 596 (2007, 2009) 7 P3, R59, A60, S103, 1106, A171, 1226 KOL 989 (2007-2009) 19 V23, R41, A56, H59, K67, V82, T84, 195, L98, N101, E112, M129 (80%), I144, V145, I171, K196, R224, A226, K229 NIV 6196 (2009-2013) 28 M6, F22, N25 (99%), G26 , L59, W67, S74, T76 , R78, I81, T86, S91, R108 (99%), 1111 (90%), I112, L119, V123 (85%), V129, N139, Y171, I198, N205 (77%), C206, D207, S213, P215, E217, * 220 Some cluster specific changes were seen in variable percentage of sequences in cluster and those absent from all other clusters are highlighted with italic font.
In Nigeria, growth is also positive, with pharmaceuticals expenditure projected to grow from
N143.65bn ($921m) in 2011 to N167.28bn ($105bn) in 2012, according to Business Monitor International's (BMI) report on the country's healthcare and pharmaceuticals industry for the third quarter of 2012.